Akerna secures world’s first national government cannabis contract with Saint Vincent and the Grenadines



The world’s first nationally adopted cannabis software will help standardize, simplify and propel the federally-run medical cannabis industry in Saint-Vincent and the Grenadines

DENVER, August 5, 2021 / PRNewswire / – Akerna Company (Nasdaq: KERN) today announces an exclusive partnership with the Medicinal Cannabis Authority (MCA) in Saint-Vincent-et-les- Grenadines (SVG). As part of this partnership, Akerna will provide MCA with a customer relationship management (CRM) tool specially developed to strengthen the medicinal cannabis industry in the Caribbean countries while meeting regulatory requirements and creating a user-friendly experience. This program will serve as a national model that can be replicated to meet all global cannabis regulations.

This program will serve as a national model that can be replicated to meet all global cannabis regulations.

The medicinal cannabis industry at SVG exists within parameters and mandates defined by local laws and international traceability treaties that govern controlled substances. These parameters require precise monitoring of medicinal cannabis which, combined with the requirements for authorization of personal possession, require significant documentation that must be completed for each patient.

The CRM implemented by Ample Organics, an Akerna company, is expected to dramatically simplify this documentation process and enable rapid assessment of the patient access platform, improving data retrieval, data availability for the patient. MCA and an overall physician, pharmacist and patient friendly experience.

“After seeing the success of Akerna’s Ample Organics product in Canada, the Medicinal Cannabis Authority of SVG was interested in partnering to create software to meet their specific regulatory and compliance needs, ”said Jessica billingsley, CEO of Akerna. “This is the first-ever implementation of a nationwide CRM system within the cannabis industry and will serve as a model for other countries or regions looking to implement a standardized system to nationwide. ”

“The new workflows will provide a better organization of information and increase the efficiency of monitoring and analysis processes, reducing the need for time, paper and human resources, in order to maximize productivity,” said said dr. Jerrol thompson, CEO of the Medicinal Cannabis Authority. “The MCA wanted to express its sincere thanks to Ample Organics and the rest of the Akerna family for guiding SVG through the various challenges of starting a cannabis market, allowing us to reach this successful stage today. ”

Saint-Vincent and the Grenadines strives to be the best regulated medicinal cannabis industry in the world Caribbean, with high quality products recognized for local use and for export, which meet the highest international and industrial standards. The vision of the cannabis industry in SVG integrates the entire value chain of this drug, including Good Agricultural and Collection Practices (GACP), Good Manufacturing Processes (GMP), export and l local patient access. The industry was designed to maximize its impact on the Vincentian workforce and economy and is expected to be an important driver of technological innovation and contribute to the growth of the agricultural, industrial, medical and tourism sectors.

About Ample Organics:

Founded in 2014 and acquired by Akerna in 2020, Ample Organics is adopted by more Canadian licensees than any other cannabis software solution. A complete ecosystem for cannabis companies, the technology platform facilitates compliance by tracking individual plants from seed to consumer and reporting every detail of the growth, production and sales processes. Our team of cannabis industry and tech experts designed the platform to facilitate compliance and transparency while improving overall business efficiency and operational intelligence. The software continues to be the most reliable solution for cannabis growers, manufacturers, distributors, physicians, clinics, laboratories, retailers and educators. Visit AmpleOrganics.com.

About Akerna:

Akerna (Nasdaq: KERN) is a service-oriented enterprise software company compliant with the cannabis, hemp, and CBD industries. Situated at Denver, Colorado, the company’s mission is to create the world’s most transparent and responsible supply chain by creating a cannabis technology ecosystem connecting data points across the global supply chain for cannabis, seed for sale to oneself. First launched in 2010, Akerna has followed more than $ 20 billion in cannabis sales to date and was the first cannabis software company listed on the Nasdaq.

Using connected data and information to power the cannabis industry, Akerna empowers businesses, governments, patients and consumers to make smart decisions. The company’s core technology, the MJ Platform, the world’s leading infrastructure as a service platform, powers retailers, manufacturers, brands, distributors and growers. Akerna also offers a full suite of professional consulting and data analysis services for business as well as solo science, MJ Freeway, Leaf Data Systems, Trellis, Ample Organics and Viridian Sciences.

About the Medicinal Cannabis Authority:

The Medicinal Cannabis Authority was created under the Medicinal Cannabis Industry Act, 2018. It is a legal person with the mandate to regulate the cultivation, supply, possession, production and use of cannabis for medical purposes. This mandate is part of the government of Saint-Vincent and the Grenadines vision to establish a well-regulated and export-oriented medicinal cannabis industry. Visit MCA.VC.

Saint-Vincent and the Grenadines has established a well-regulated, high-quality, export-oriented medicinal cannabis industry. He strives to be a leader and an example of how a small nation with big dreams, ideas and well-designed plans can successfully establish a world-class medicinal cannabis industry. A critical part of this is the local availability of medicinal cannabis for local patients and visitors with appropriate eligible diseases and to do so in a very efficient and professional manner.

Forward-looking statements

Certain statements made in this press release and any accompanying statements by management are “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, words “estimates”, “plans”, “expects”, “anticipates”, “plans”, “plans”, “intention”, “believes”, “research”, “may”, “may”, “should” , “Should”, “the future”, “propose” and variations of such similar words or phrases (or negative versions of such words or phrases) are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding the CRM implemented by Ample which are expected to significantly simplify the documentation process and enable rapid assessment of the Patient Access Platform, improving data retrieval. , availability of data for the MCA and overall user-friendly experience and any other statements expressing the views of Akerna management on future business results or strategy. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are beyond the control of ‘Akerna, which could lead to actual results or results. (including, without limitation, the results of Akerna’s contracts, strategic initiatives and business plans as described herein) differ materially from those discussed in the forward-looking statements. Important factors, among others that may affect results or actual results, include (i) Akerna’s ability to recognize the expected benefits of being a public company, (ii) competition, (iii) ability of Akerna to grow and manage its growth profitably, (iv) Akerna’s ability to maintain customer and supplier relationships and retain its management and key employees, (v) costs associated with to be a public company, (vi) changes in applicable laws or regulations, (vii) Akerna’s ability to identify, complete and integrate acquisitions, including Viridian, and achieve expected synergies and operational efficiencies in in connection with the acquired businesses, (viii) and other risks and uncertainties disclosed from time to time in the documents filed by Akerna with the United States Securities and Exchange Commission, including those mentioned in section n “Risk factors”. Actual results, performance or achievements may differ materially, and potentially negatively, from any projections and forward-looking statements and the assumptions on which they differ from forward-looking statements. There can be no assurance that the data contained in this document reflects to any degree future performance. You are cautioned not to place undue reliance on forward-looking statements as predictors of future performance, as projected financial and other information is based on estimates and assumptions which are inherently subject to various risks, uncertainties and other important factors, including many are beyond Akerna’s control. All information contained herein is valid only as of the date hereof, in the case of information about Akerna, or as of the date of such information, in the case of information from persons other than Akerna. Akerna assumes no obligation to update or revise the information contained in this document. Forecasts and estimates for Akerna’s industry and end markets are based on sources believed to be reliable; however, there can be no assurance that such forecasts and estimates will prove to be correct in whole or in part.

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/akerna-secures-worlds-first-national-government-cannabis-contract-with-st-vincent-and-the-grenadines -301349313 .html



Leave A Reply

Your email address will not be published.